Impact and clinical profiles of Mycoplasma pneumoniae co-detection in childhood community-acquired pneumonia

Mengchuan Zhao(Hebei General Hospital), Guixia Li(Hospital of Hebei Province), Fang-zhou Qiu(Tianjin Children's Hospital), Le Wang(Hospital of Hebei Province), Li Zhao(Hebei Medical University), Weiwei Guo(University of Science and Technology of China), Shuo Yang(National Institute for Parasitic Diseases), Zhishan Feng(Hebei Medical University)
BMC Infectious Diseases
October 11, 2019
10.1186/s12879-019-4426-0
Cited by 29

Related Papers

Epidemiology of respiratory pathogens in patients with acute respiratory infections during the COVID‐19 pandemic and after easing of COVID‐19 restrictions
|Microbiology Spectrum|2024|69
A comparative study of general and severe mycoplasma pneumoniae pneumonia in children
|BMC Infectious Diseases|2024|68
A comparison study between GeXP-based multiplex-PCR and serology assay for Mycoplasma pneumoniae detection in children with community acquired pneumonia
|BMC Infectious Diseases|2017|65
Targeting GRP75 Improves HSP90 Inhibitor Efficacy by Enhancing p53-Mediated Apoptosis in Hepatocellular Carcinoma
|PLoS ONE|2014|41
Comparing the yield of oropharyngeal swabs and sputum for detection of 11 common pathogens in hospitalized children with lower respiratory tract infection
|Virology Journal|2019|33